Delivery Order SPE2DB20D1100-SPE2DB25FC0L9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,156.88 by the Defense Logistics Agency Medical Supply Chain on July 25, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is a child contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,049.99 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 26, 2025. The award was issued on August 25, 2025, with no set-aside designation applied. This delivery order is a child contract executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $95,223.63 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, open-market award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This competitive, firm fixed-price delivery order has a ceiling value of $66,244.88 and an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,180.32 by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets (60-count) with a ceiling value of $26,140.92. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets in quantities of 60s, with a ceiling value of $12,825.81. The contract is classified as a Firm Fixed Price delivery order with an ultimate completion date of September 5, 2025, and was competitively awarded without a set-aside designation. The product will be sourced from the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for Eliquis 5 mg tablets (60-count units) valued at $7,758.02 by the Defense Logistics Agency. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 8, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC0L9Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,311.84 by the Defense Logistics Agency (DLA) on April 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract, which is not set-aside, utilizes firm fixed pricing and carries an ultimate completion date of May 1, 2025. Performance of this order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical (designated SPE2DX) valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply agreement supporting military healthcare operations globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected for this award based on its demonstrated capability to meet federal requirements. The company supplies a broad portfolio of medications and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Eliquis—an anticoagulant medication commonly used in military and veteran healthcare settings—represents a routine fulfillment under the broader DLA pharmaceutical prime vendor contract that encompasses brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 4/30/25 |